Jan 1, 2026 · Asciminib is used to treat Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) in patients who are newly diagnosed or who have received …

Asciminib is an ABL/BCR-ABL1 tyrosine kinase inhibitor. Asciminib inhibits the ABL1 kinase activity of the BCR::ABL1 fusion protein, by binding to the ABL myristoyl pocket.

Asciminib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells). Asciminib is in a class of medications called kinase inhibitors.

Asciminib, a BCR::ABL1 inhibitor specifically targeting the ABL myristoyl pocket, may offer better efficacy and safety and fewer side effects than currently available frontline ATP-competitive...

Asciminib, sold under the brand name Scemblix, is a medication used to treat Philadelphia chromosome -positive chronic myeloid leukemia (Ph+ CML). [5][7][8] Asciminib is a protein kinase inhibitor.

Dec 12, 2022 · Asciminib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to …

ASCIMINIB (as SIM i nib) treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. This medicine may be used …

Learn more about SCEMBLIX® (asciminib) tablets, a treatment for adults with Ph+ CML in chronic phase. See full Prescribing and Safety Information.

This page contains brief information about asciminib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

How does asciminib work? Asciminib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that act as chemical messengers and can stimulate cancer cells …